Home » Authors » Karl Thiel

Articles by Karl Thiel

Supreme Court Actions Add Pressure to Beleaguered FDA

March 3, 2008

Supreme Court Actions Add Pressure to Beleaguered FDA

March 3, 2008

In-license to Lower Risk? Nice Idea, But No Thanks

Jan. 22, 2008

In-license to Lower Risk? Nice Idea, But No Thanks

Jan. 22, 2008

Activist Shareholder Tallysheet: Fast Cash, But Chaos, Disruption

Dec. 26, 2007

Come On, Life Sciences, Let's Feel The Hostility

Nov. 26, 2007

Come On, Life Sciences, Let's Feel The Hostility

Nov. 26, 2007

Part D, Part B Or Part Z, It's About Price Control

Oct. 22, 2007

Part D, Part B Or Part Z, It's About Price Control

Oct. 22, 2007

As Biogenerics Debate Evolves, The More It Remains The Same

Aug. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...